In the published article, there was an error. Two words were misspelled.
A correction has been made to Conclusions, Paragraph One. This sentence previously stated:
“Compared with PD-1 inhibitors, PD-L1 inhibitors might increase the incidence of any-grade pneumonitis.”
The corrected sentence appears below:
“Compared with PD-L1 inhibitors, PD-1 inhibitors might increase the incidence of any-grade pneumonitis.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
esophageal cancer, safety, toxicity profile, immune checkpoint inhibitors, thoracic radiotherapy, systemic analysis
Citation
Xu T, Liu Y, Lu X and Liang J (2023) Corrigendum: Toxicity profile of combined immune checkpoint inhibitors and thoracic radiotherapy in esophageal cancer: A meta-analysis and systematic review. Front. Immunol. 14:1193710. doi: 10.3389/fimmu.2023.1193710
Received
25 March 2023
Accepted
30 March 2023
Published
11 April 2023
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
14 - 2023
Updates
Copyright
© 2023 Xu, Liu, Lu and Liang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jun Liang, liang23400@163.com
This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Immunology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.